Cornercap Investment Counsel’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,078
Closed -$211K 213
2024
Q4
$211K Hold
3,078
0.07% 432
2024
Q3
$221K Sell
3,078
-3,276
-52% -$231K 0.07% 470
2024
Q2
$440K Sell
6,354
-38
-0.6% -$2.77K 0.07% 496
2024
Q1
$512K Buy
+6,392
New +$570K 0.08% 443
2020
Q2
Sell
-12,643
Closed -$724K 431
2020
Q1
$724K Buy
+12,643
New +$1.17M 0.14% 255
2013
Q4
Sell
-10,450
Closed -$355K 235
2013
Q3
$355K Buy
10,450
+210
+2% +$6.85K 0.07% 175
2013
Q2
$320K Buy
+10,240
New +$332K 0.07% 148

Other funds holding CNMD

Cornercap Investment Counsel's CNMD Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of CONMED (CNMD) in Q1 2025, closing a stake of 3,078 shares — an estimated $211K sold.

Cornercap Investment Counsel first reported a position in CNMD in Q2 2013 and held it in 7 quarters. The position peaked at $724K in Q1 2020. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Cornercap Investment Counsel reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 3,078 CONMED shares in Q1 2025, an estimated $211K.
  • Cornercap Investment Counsel first reported a position in CONMED in Q2 2013 and held it in 7 quarters.
  • Cornercap Investment Counsel's CONMED position peaked at $724K in Q1 2020.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.